Skip to Main Content

Paper Details

Risk of heart disease following treatment for breast cancer - results from a population-based cohort study.
Elife
8
2022
Aromatase, Cancer, Trastuzumab, anthracyclines, arrhythmia, breast cancer, cardiotoxicities, heart disease, heart failure, ischemic heart disease, patient, patients, tamoxifen
Author NameAffiliation
Felix GrassmannKarolinska Institutet
Felix GrassmannHealth and Medical University
Jonas F LudvigssonKarolinska Institutet
Jonas F LudvigssonOrebro University Hospital
Per HallKarolinska Institutet
Per Hall
  • 1 - 6

Datasets

Release 1.2